Add Company
Join Now

Twenty/Twenty Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical Equip

Industry

Estimated Revenue & Valuation

  • Twenty/Twenty Therapeutics's estimated annual revenue is currently $17.6M per year.(i)
  • Twenty/Twenty Therapeutics's estimated revenue per employee is $798,636

Employee Data

  • Twenty/Twenty Therapeutics has 22 Employees.(i)
  • Twenty/Twenty Therapeutics grew their employee count by -61% last year.

Twenty/Twenty Therapeutics's People

NameTitleEmail/Phone
1
Executive Assistant To CEOReveal Email/Phone
2
President and CEOReveal Email/Phone
3
Chief Business OfficerReveal Email/Phone
4
VP, Business Development and Head Digital TherapeuticsReveal Email/Phone
5
Director ManufacturingReveal Email/Phone
6
Director Product MarketingReveal Email/Phone
7
Sr. Technical Project ManagerReveal Email/Phone
8
Program ManagerReveal Email/Phone
9
Senior Clinical Study ManagerReveal Email/Phone
10
Program ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M7920%N/AN/A
#2
$8.5M3111%N/AN/A
#3
$4.5M13-13%N/AN/A
#4
$8M25-4%N/AN/A
#5
$5.3M16-6%N/AN/A
#6
$54.2M163-8%N/AN/A
#7
$12M55-17%N/AN/A
#8
$10M30-9%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M43-7%N/AN/A
Add Company

What Is Twenty/Twenty Therapeutics?

Our mission is to improve eye health for people everywhere, starting by developing solutions to support modern ophthalmology practice globally. We will capitalize on our expertise in the development of connected, integrated medical devices and machine learning along with our vast knowledge in the ophthalmology field and we will create and commercialize unique ophthalmic devices and comprehensive tech-enabled solutions.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$17.6M

Revenue (est)

-61%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M22-80%$187M
#2
$3.7M2441%N/A
#3
$2.4M24N/AN/A
#4
$3.6M2426%N/A
#5
$2.5M25-32%N/A